ArticleAllergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology2021

Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases.

Hiroyuki Yazu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.